{"id":"W2132193955","doi":"10.1093/annonc/mdq357","title":"A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Ovarian cancer; Dosing; Oncology; Tyrosine-kinase inhibitor; Adverse effect; Gastroenterology; Progressive disease; Phases of clinical research; Cancer; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002435836,0.001795145,0.004372139,0.0005141902,0.0006840837,0.001059179,0.0009639284,0.001605249,0.004016118],"category_scores_gemma":[0.001729901,0.0005771663,0.002710733,0.0005440854,0.001011144,0.001142417,0.0004312914,0.003138666,0.0007738737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001161502,"about_ca_system_score_gemma":0.001751236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002168722,"about_ca_topic_score_gemma":0.005782609,"domain_scores_codex":[0.9992488,0.0004220589,0.00003749492,0.0001221926,0.00005736161,0.0001119961],"domain_scores_gemma":[0.9985856,0.0002958463,0.0002879896,0.0001236614,0.00007670627,0.0006303146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9240094,0.01726012,0.007627487,0.000962009,0.00340514,0.0001880795,0.0002044539,0.001413823,0.008010724,0.0001672035,0.002819214,0.03393238],"study_design_scores_gemma":[0.8662491,0.1167568,0.01309483,0.00002397816,0.001314499,0.0001674513,0.00006005793,0.0005177764,0.0005842256,0.000111349,0.001093432,0.0000265073],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918804,0.003180841,0.0002624435,0.000563467,0.0001672119,0.001498706,0.001023073,0.00007466212,0.001349234],"genre_scores_gemma":[0.9912521,0.002003084,0.0006888044,0.0007681612,0.000237187,0.001573419,0.001731885,0.00002897589,0.001716343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004372139,"threshold_uncertainty_score":0.0134353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1815910300526322,"score_gpt":0.485284439144716,"score_spread":0.3036934090920838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}